Diabetes Distress or Major Depressive Disorder? A Practical Approach to Diagnosing and Treating Psychological Comorbidities of Diabetes Kathryn Evans Kreider PRACTICAL APPROACH Open access 03 February 2017 Pages: 1 - 7
How Can a Good Idea Fail? Basal Insulin Peglispro [LY2605541] for the Treatment of Type 2 Diabetes Araceli Muñoz-GarachMaría Molina-VegaFrancisco J. Tinahones Review Open access 28 November 2016 Pages: 9 - 22
Lack of Evidence to Guide Deprescribing of Antihyperglycemics: A Systematic Review Cody D. BlackWade ThompsonBarbara Farrell Review Open access 15 December 2016 Pages: 23 - 31
Empagliflozin: Role in Treatment Options for Patients with Type 2 Diabetes Mellitus John E. AndersonEugene E. Wright Jr.Charles F. Shaefer Jr. Review Open access 11 November 2016 Pages: 33 - 53
Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial Thomas HaakHélène HanaireGerry Rayman Original Research Open access 20 December 2016 Pages: 55 - 73
Fear of Self-Injecting and Self-Testing and the Related Risk Factors in Adolescents with Type 1 Diabetes: A Cross-Sectional Study Ayman A. Al HayekAsirvatham A. RobertMohamed A. Al Dawish Original Research Open access 19 December 2016 Pages: 75 - 83
Liraglutide Versus SGLT-2 Inhibitors in People with Type 2 Diabetes: A Network Meta-Analysis Maria LorenziUffe Jon PlougJeroen Jansen Original Research Open access 19 December 2016 Pages: 85 - 99
The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical Trial Sultan LinjawiBruce W. BodeRichard W. Simpson Original Research Open access 10 December 2016 Pages: 101 - 114
GLP-1 RA Treatment Patterns Among Type 2 Diabetes Patients in Five European Countries Victoria DivinoMitch DeKovenKirsi Norrbacka Original Research Open access 09 January 2017 Pages: 115 - 128
Evaluating the Long-Term Cost-Effectiveness of Daily Administered GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes in the United Kingdom Barnaby HuntQing YeDonna Ashley Original Research Open access 05 January 2017 Pages: 129 - 147
Basal Insulin Persistence, Associated Factors, and Outcomes After Treatment Initiation: A Retrospective Database Study Among People with Type 2 Diabetes Mellitus in Japan Irene HadjiyianniUrvi DesaiMagaly Perez-Nieves Original Research Open access 02 December 2016 Pages: 149 - 166
Costs of Managing Patients with Diabetes in a Large Health Maintenance Organization in Israel: A Retrospective Cohort Study Avi PorathNaama FundYasmin Maor Original Research Open access 16 November 2016 Pages: 167 - 176
Exenatide Add-on to Continuous Subcutaneous Insulin Infusion Therapy Reduces Bolus Insulin Doses in Patients with Type 2 Diabetes: A Randomized, Controlled, Open-Label Trial Feng-fei LiLanlan JiangJian-hua Ma Original Research Open access 19 December 2016 Pages: 177 - 187
Insulin Degludec in Clinical Practice: A Review of Japanese Real-World Data Kohei KakuMichael Lyng WoldenEmil Nørtoft Brief Report Open access 13 January 2017 Pages: 189 - 195
Intensification of IDegAsp Twice Daily (Adding Insulin Aspart vs. Switching To Basal–Bolus): Exploratory Randomized Trial in Type 2 Diabetes Wan Mohamaed Wan BebakarLouis ChaykinSøren Rasmussen Brief Report Open access 16 November 2016 Pages: 197 - 205
Erratum to: Simvastatin Rapidly and Reversibly Inhibits Insulin Secretion in Intact Single-Islet Cultures Valentina ScattoliniCamilla LuniGian Paolo Fadini Erratum Open access 30 November 2016 Pages: 207 - 207